Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DELCATH SYSTEMS, INC. Director's Dealing 2024

May 28, 2024

33086_dirs_2024-05-28_876eb502-0345-49c1-b2a3-38c674ef6475.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DELCATH SYSTEMS, INC. (DCTH)
CIK: 0000872912
Period of Report: 2024-05-23

Reporting Person: STOLL ROGER G PHD (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-23 Stock Option (Right to Buy) $196.70 D 142 Disposed 2029-02-01 Common Stock (142) Direct
2024-05-23 Stock Option (Right to Buy) $196.70 A 142 Acquired 2026-05-23 Common Stock (142) Direct
2024-05-23 Stock Option (Right to Buy) $11.67 D 40000 Disposed 2030-10-01 Common Stock (40000) Direct
2024-05-23 Stock Option (Right to Buy) $11.67 A 40000 Acquired 2026-05-23 Common Stock (40000) Direct
2024-05-23 Stock Option (Right to Buy) $10.16 D 9000 Disposed 2031-08-05 Common Stock (9000) Direct
2024-05-23 Stock Option (Right to Buy) $10.16 A 9000 Acquired 2026-05-23 Common Stock (9000) Direct
2024-05-23 Stock Option (Right to Buy) $6.24 D 9000 Disposed 2023-05-04 Common Stock (9000) Direct
2024-05-23 Stock Option (Right to Buy) $6.24 A 9000 Acquired 2026-05-23 Common Stock (9000) Direct
2024-05-23 Stock Option (Right to Buy) $7.25 D 19682 Disposed 2033-06-12 Common Stock (19682) Direct
2024-05-23 Stock Option (Right to Buy) $7.25 A 19682 Acquired 2026-05-23 Common Stock (19682) Direct

Footnotes

F1: This option was previously reported as covering 100,000 shares at an exercise price of $0.281 per share, but was adjusted to reflect the stock split that occurred on December 24, 2019.

F2: The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on February 1, 2019 and is fully vested.

F3: The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 23, 2020 and is fully vested.

F4: The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on August 5, 2021 and is fully vested.

F5: The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on May 4, 2022 and is fully vested.

F6: The two reported transactions involved an amendment of an outstanding option to extend the post-termination exercise period, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 12, 2023 and is fully vested.